Seraxis
William L. Rust, Ph.D. has extensive work experience in various roles and positions in the biotechnology and pharmaceutical industry. William L. currently serves as the President and CEO of Seraxis. Prior to this role, they worked as a Senior Communications Manager at AABB from August 2012 to February 2013. Before that, they held the position of Director of Product Development at ATCC from 2010 to 2011. From 2008 to 2010, they worked as a Section Manager for Cell Systems at Lonza. Prior to that, they worked as a Senior Scientist at ES Cell International from 2003 to 2008 and as a Research Fellow at Novartis from 2001 to 2003.
William L. Rust, Ph.D. completed their education in the field of Biological Sciences at the University of Nevada-Las Vegas. William L. obtained their Ph.D. degree, specializing in this discipline, during the period from 1997 to 2001.
This person is not in any teams
Seraxis
Seraxis is a private biotechnology company launched in March 2013. Incorporated in Singapore and the United States, their GMP lab is located in Germantown, Maryland. Seraxis team of scientists developed novel cell and encapsulation technologies. Their main goal is to bring a practical cell therapy for insulin-dependent diabetes to the clinic andprovide a long term cure to patients that does not require the use of immuno-suppression.Their corporate structure and strategy is designed to achieve that goal as quickly as possible, while bringing maximum value to their shareholders.